STOCK TITAN

80,000 Zeo ScientifiX (ZEOX) stock options granted to company director

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zeo ScientifiX, Inc. director Bretz Charles Luther received a grant of stock options to buy 80,000 shares of common stock. The options have an exercise price of $1.67 per share, were fully vested on the June 10, 2026 grant date, and expire on June 10, 2031. Following this award, he holds stock options covering 80,000 underlying shares as direct derivative holdings, reflecting equity-based compensation rather than an open-market trade.

Positive

  • None.

Negative

  • None.
Insider Bretz Charles Luther
Role null
Type Security Shares Price Value
Grant/Award Stock Options 80,000 $0.00 --
Holdings After Transaction: Stock Options — 80,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Stock options granted 80,000 options Grant to director on June 10, 2026
Exercise price $1.67 per share Stock options granted under 2021 Equity Incentive Plan
Underlying shares 80,000 shares Common stock underlying granted options
Options expiration June 10, 2031 Expiration date of granted stock options
Derivative holdings after grant 80,000 options Total stock options following this transaction
Stock Options financial
"Represents the grant of stock options to purchase shares of the Issuer's common stock"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
2021 Equity Incentive Plan financial
"under its 2021 Equity Incentive Plan (the "2021 Plan")"
exercise price financial
"conversion_or_exercise_price": "1.6700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2031-06-10T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Zeo ScientifiX (ZEOX) report for Bretz Charles Luther?

Zeo ScientifiX reported that director Bretz Charles Luther received a grant of stock options for 80,000 shares of common stock. These options represent equity-based compensation rather than an open-market purchase or sale of existing shares.

How many Zeo ScientifiX (ZEOX) stock options were granted in this Form 4?

The Form 4 shows a grant of stock options covering 80,000 underlying shares of Zeo ScientifiX common stock. This entire amount was awarded in a single transaction and is now reflected in the director’s derivative holdings.

What is the exercise price of the Zeo ScientifiX (ZEOX) options granted to the director?

The granted stock options have an exercise price of $1.67 per share. This is the price at which the director can purchase Zeo ScientifiX common stock through these options if he chooses to exercise them before expiration.

When do the newly granted Zeo ScientifiX (ZEOX) stock options expire?

The stock options granted to the director expire on June 10, 2031. He may choose to exercise them any time before that date, subject to the terms and conditions of Zeo ScientifiX’s 2021 Equity Incentive Plan.

Did the Zeo ScientifiX (ZEOX) director buy or sell shares on the market in this filing?

No market purchase or sale occurred in this filing. The director received a grant of stock options as compensation, with no open-market buy or sell transactions reported for Zeo ScientifiX common stock.

What vesting terms apply to the Zeo ScientifiX (ZEOX) stock options granted?

The filing states the stock options vested in full as of the grant date. This means the director’s entire 80,000-share option award became fully exercisable immediately, subject to the other terms of the 2021 Equity Incentive Plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bretz Charles Luther

(Last)(First)(Middle)
3321 COLLEGE AVENUE
SUITE 246

(Street)
DAVIE FLORIDA 33314

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Zeo ScientifiX, Inc. [ ZEOX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options$1.6706/10/2026A(1)80,00006/10/2026(1)06/10/2031Common Stock80,000$080,000D
Explanation of Responses:
1. Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date and are subject to the other terms and conditions of the 2021 Plan.
/s/ Charles Luther Bretz06/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)